ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma

ADAM metallopeptidase domain 12 (ADAM12) is a promising biomarker because of its low expression in normal tissues and high expression in a variety of human cancers. However, ADAM12 levels in ovarian cancer have not been well characterized. We previously identified ADAM12 as one of the signature gene...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Carcinogenesis
Päätekijät: Cheon, Dong-Joo, Li, Andrew J., Beach, Jessica A., Walts, Ann E., Tran, Hang, Lester, Jenny, Karlan, Beth Y., Orsulic, Sandra
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Original Manuscript
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7500073/
https://ncbi.nlm.nih.gov/pubmed/25926422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgv059
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia